Factors Affecting the Price of Zydelig

Zydelig (idelalisib), used for certain cancers, has a price influenced by multiple factors. High R&D costs play a major role as developing this kinase inhibitor requires extensive research and clinical trials.

Factors Affecting the Price of Zydelig

Since it's only available as a brand - name drug without generics yet, its patent protection allows Gilead Sciences to set a relatively high price. Production costs, including those for specialized manufacturing and quality control, also contribute.

Market demand from patients with relapsed chronic lymphocytic leukemia and other relevant cancers affects the price. Moreover, geographical location matters; prices can vary between regions due to different healthcare policies and distribution channels. Insurance coverage and available patient assistance programs further influence the out - of - pocket cost for patients.